医薬中間体の世界市場:産業分析・市場機会

【英語タイトル】Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029

Future Market Insightsが出版した調査資料(FUMI906093)・商品コード:FUMI906093
・発行会社(調査会社):Future Market Insights
・発行日:2019年4月
・ページ数:275
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、医薬中間体の世界市場について調査・分析し、以下の構成でお届けいたします。
・医薬中間体の世界市場の世界市場概観
・医薬中間体の世界市場の世界市場規模
・医薬中間体の世界市場の世界市場予測
・医薬中間体の世界市場の世界市場:地域別市場分析
・医薬中間体の世界市場のアメリカ市場規模
・医薬中間体の世界市場のヨーロッパ市場規模
・医薬中間体の世界市場のアジア市場規模
・医薬中間体の世界市場の世界市場:製品別(化学的中間体、原薬中間体、カスタム中間体)
・医薬中間体の世界市場の世界市場:競争状況
・医薬中間体の世界市場の世界市場:市場動向
・医薬中間体の世界市場の世界市場:関連企業分析
【レポートの概要】

FMI has compiled a study on the pharmaceutical intermediates market, which offers an analysis and forecast of the Pharmaceutical Intermediates market in its publication titled ‘Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the Pharmaceutical intermediates market covers some of the key influencing factors on the demand and supply of Pharmaceutical Intermediates over the next several years. An in-depth review of the growth drivers, potential challenges, unique trends, and opportunities for the market participants is expected to equip readers to fully comprehend the overall landscape of the Pharmaceutical Intermediates market.

The report on the pharmaceutical intermediates market also covers an analysis of the key regions and countries of particular interest, which are estimated to become frontrunners or remain laggards over the forecast period. The report covers a historical analysis of the market from 2014 to 2018, and provides forecasts from 2019 to 2029 in terms of revenue in US$.

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. There are different types of pharmaceutical intermediates and demand of each type of the pharmaceutical intermediates is high due to increasing pharmaceutical and biopharmaceutical production.

This report on the pharmaceutical intermediates market has been broken down into different chapters to enhance clarity and provide context. A brief executive summary at the beginning of the report consists of some of the key findings of the study on the pharmaceutical intermediates market, as well as market estimates and growth rates for important segments. The following chapter presents the definitions and scope of the study, as well as the coverage in terms of the way in which the pharmaceutical intermediates market is structured.

Subsequently, the chapter on the market background contains relevant economic indicators, such as per capita healthcare spending and increase in cancer cases, which elaborate the dynamics impacting the pharmaceutical intermediates market, as well as provides an explanation of the factors considered important to develop forecasts and estimates. The following chapters dive deep into the global pharmaceutical intermediates market, covering detailed information based on product type, application and end user. The next set of chapters provide a region-wise analysis and forecasts of the pharmaceutical intermediates market, which cover the vital aspects of the market in North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

A dashboard view of some of the key companies operating in the pharmaceutical intermediates market in terms of their offerings, regional presence, and other metrics is a precursor to the detailed profiles of these participants, which include their financial information, strategy overview, and products offered, SWOT analysis as well as analyst commentary. Some of the key players analyzed in the Pharmaceutical Intermediates market report include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema Inc and Cambrex Corporation among others.

To develop the estimates for the pharmaceutical intermediates market, the global adoption/consumption of pharmaceutical intermediates was taken into account, which was followed by tracking key players and their product offering globally. This is then cross-referenced with the revenue generated from the sales of pharmaceutical intermediates for top companies globally.

Our team of analysts reviews and interpret data from a variety of sources. The data attributed to ‘FMI’ is derived by using a combination of various approaches, which are then consolidated, interpreted, and extrapolated by FMI analysts. Data is sourced from government statistics, trade associations, company annual reports, investor presentations, press articles & directories, technical publications, and online databases, which are cross-referenced with FMI’s reports and internal repository of data to filter and validate the collected information.

The intelligence gathered from desk research is supplemented by extensive interviews with selected key expert participants across the value chain not only to gain information specific to their role and operations, but also to obtain their perspective and insights of the issues impacting the pharmaceutical intermediates market.

Global Pharmaceutical Intermediates Market: Segmentation

Analysis by Product Type

Chemical Intermediates

Bulk Drug Intermediates

Chiral Intermediates

Achiral Intermediates

Custom Intermediates

Analysis by Category

Branded Drug Intermediates

Generic Drug Intermediates

Analysis by Application/Drug Type

Analgesics

Anti-Infective Drugs

Cardiovascular Drugs

Oral Antidiabetic Drugs

Antimicrobial Drugs

Others

Analysis by End User

Biotech & Pharma Companies

Research Laboratories

CMOs/CROs

Analysis by Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East & Africa

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Product USPs / Features

4.3. Strategic Promotional Activities, By Key Manufacturers

5. Global Pharmaceutical Intermediates Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Increasing Healthcare R & D Spending

6.1.2. Emergence of Academia as the Primary Organisation for Carrying Out Basic Research

6.2. Forecast Factors – Relevance & Impact

6.2.1. Prevalence of Chronic Diseases

6.2.2. Increased Government Focus on Generic Drugs

6.2.3. Growing Demand for Biologics and Specialty Drugs

6.2.4. Production Capacity Growth

6.2.5. Top Companies Historic Average Growth

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 – 2017

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2018 – 2018

7.3.1. Chemical Intermediates

7.3.2. Bulk Drug Intermediates

7.3.2.1. Chiral Intermediates

7.3.2.2. Achiral Intermediates

7.3.3. Custom Intermediates

7.4. Market Attractiveness Analysis By Product Type

8. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Category

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Category, 2013 – 2017

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Category, 2018 – 2018

8.3.1. Branded Drug Intermediates

8.3.2. Generic Drug Intermediates

8.4. Market Attractiveness Analysis By Category

9. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Application

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Application, 2013 – 2017

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2018 – 2018

9.3.1. Analgesics

9.3.2. Anti-Infective Drugs

9.3.3. Cardiovascular Drugs

9.3.4. Oral Antidiabetic Drugs

9.3.5. Antimicrobial Drugs

9.3.6. Others

9.4. Market Attractiveness Analysis By Application

10. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By End User, 2013 – 2017

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2018 – 2018

10.3.1. Biotech & Pharma Companies

10.3.2. Research Laboratories

10.3.3. CMOs/CROs

10.4. Market Attractiveness Analysis By End User

11. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Region

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 – 2017

11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 – 2018

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. Middle East and Africa (MEA)

11.3.5. East Asia

11.3.6. South Asia

11.3.7. Oceania

11.4. Market Attractiveness Analysis By Region

12. North America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Product Type

12.3.3. By Category

12.3.4. By Application

12.3.5. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Category

12.4.4. By Application

12.4.5. By End User

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Rest of Latin America

13.3.2. By Product Type

13.3.3. By Category

13.3.4. By Application

13.3.5. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Category

13.4.4. By Application

13.4.5. By End User

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. France

14.3.1.3. Italy

14.3.1.4. U.K.

14.3.1.5. BENELUX

14.3.1.6. Russia

14.3.1.7. Rest of Europe

14.3.2. By Product Type

14.3.3. By Category

14.3.4. By Application

14.3.5. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Category

14.4.4. By Application

14.4.5. By End User

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Product Type

15.3.3. By Category

15.3.4. By Application

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Category

15.4.4. By Application

15.4.5. By End User

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product Type

16.3.3. By Category

16.3.4. By Application

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Category

16.4.4. By Application

16.4.5. By End User

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Product Type

17.3.3. By Category

17.3.4. By Application

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Category

17.4.4. By Application

17.4.5. By End User

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

18.1. Introduction

18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. South Africa

18.3.1.3. North Africa

18.3.1.4. Turkey

18.3.1.5. Rest of MEA

18.3.2. By Product Type

18.3.3. By Category

18.3.4. By Application

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Product Type

18.4.3. By Category

18.4.4. By Application

18.4.5. By End User

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Emerging Countries Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. China Pharmaceutical Intermediates Market Analysis

19.2.1. Introduction

19.2.2. PEST Analysis

19.2.3. Market Value Proportion Analysis by Market Taxonomy

19.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

19.2.4.1. By Product Type

19.2.4.2. By Category

19.2.4.3. By Application

19.2.4.4. By End User

19.2.5. China Pharmaceutical Intermediates Market – Competition Landscape

19.2.6. China – Trade Analysis

19.3. India Pharmaceutical Intermediates Market Analysis

19.3.1. Introduction

19.3.2. PEST Analysis

19.3.3. Market Value Proportion Analysis by Market Taxonomy

19.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

19.3.4.1. By Product Type

19.3.4.2. By Category

19.3.4.3. By Application

19.3.4.4. By End User

19.3.5. India Pharmaceutical Intermediates Market – Competition Landscape

19.4. Russia Pharmaceutical Intermediates Market Analysis

19.4.1. Introduction

19.4.2. PEST Analysis

19.4.3. Market Value Proportion Analysis by Market Taxonomy

19.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

19.4.4.1. By Product Type

19.4.4.2. By Category

19.4.4.3. By Application

19.4.4.4. By End User

19.4.5. Russia Pharmaceutical Intermediates Market – Competition Landscape

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies (Pharmaceutical Intermediates)

20.2. Market Concentration

20.3. Market Share Analysis of Top Players

20.4. Market Presence Analysis

20.4.1. By Regional footprint of Players

20.4.2. Product foot print by Players

20.4.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Chiracon GmbH

21.3.1.1. Company Overview

21.3.1.2. Analyst Commentary

21.3.1.3. Financial Analysis

21.3.1.4. Product Portfolio

21.3.1.5. Profitability by Market Segments (Product and Region)

21.3.1.6. Sales Footprint

21.3.1.7. Strategy Overview

21.3.1.7.1. Marketing Strategy

21.3.1.7.2. Product Strategy

21.3.1.7.3. Channel Strategy

21.3.2. Aceto Corporation

21.3.3. Midas Pharma GmbH

21.3.4. Codexis, Inc.

21.3.5. Lianhetech

21.3.6. BASF SE

21.3.7. Vertellus Holdings LLC

21.3.8. Sanofi Winthrop Industrie S.A.

21.3.9. A.R. Life Sciences Private Limited

21.3.10. Dishman Group

21.3.11. Chemcon Specialty Chemical Pvt. Ltd.

21.3.12. Dextra Laboratories Limited

21.3.13. ZCL Chemicals Ltd.

21.3.14. Easter Chemical Corporation

21.3.15. Pfizer, Inc.

21.3.16. Bristol-Myers Squibb Company

21.3.17. Arkema Inc.

21.3.18. Interchem

21.3.19. Cambrex Corporation

22. Assumptions and Acronyms Used

23. Research Methodology



★調査レポート[医薬中間体の世界市場:産業分析・市場機会] (コード:FUMI906093)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬中間体の世界市場:産業分析・市場機会]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆